151 related articles for article (PubMed ID: 28621612)
1. Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population.
Taheri M; Pouresmaeili F; Omrani MD; Habibi M; Sarrafzadeh S; Noroozi R; Rakhshan A; Sayad A; Ghafouri-Fard S
Biomark Med; 2017 May; 11(5):413-422. PubMed ID: 28621612
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants within ANRIL (antisense non coding RNA in the INK4 locus) are associated with risk of psoriasis.
Rakhshan A; Zarrinpour N; Moradi A; Ahadi M; Omrani MD; Ghafouri-Fard S; Taheri M
Int Immunopharmacol; 2020 Jan; 78():106053. PubMed ID: 31812071
[TBL] [Abstract][Full Text] [Related]
3. HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population.
Taheri M; Habibi M; Noroozi R; Rakhshan A; Sarrafzadeh S; Sayad A; Omrani MD; Ghafouri-Fard S
Gene; 2017 May; 613():20-24. PubMed ID: 28259691
[TBL] [Abstract][Full Text] [Related]
4.
Khorshidi HR; Taheri M; Noroozi R; Sarrafzadeh S; Sayad A; Ghafouri-Fard S
Cell J; 2017; 19(Suppl 1):72-78. PubMed ID: 28580310
[TBL] [Abstract][Full Text] [Related]
5. Association Study of ANRIL Genetic Variants and Multiple Sclerosis.
Rezazadeh M; Gharesouran J; Moradi M; Noroozi R; Omrani MD; Taheri M; Ghafouri-Fard S
J Mol Neurosci; 2018 May; 65(1):54-59. PubMed ID: 29713948
[TBL] [Abstract][Full Text] [Related]
6. Association Analysis of ANRIL Polymorphisms and Haplotypes with Autism Spectrum Disorders.
Safa A; Noroozi R; Taheri M; Ghafouri-Fard S
J Mol Neurosci; 2021 Jan; 71(1):187-192. PubMed ID: 32623644
[TBL] [Abstract][Full Text] [Related]
7. ANRIL Variants Are Associated with Risk of Neuropsychiatric Conditions.
Namvar A; Kahaei MS; Fallah H; Nicknafs F; Ghafouri-Fard S; Taheri M
J Mol Neurosci; 2020 Feb; 70(2):212-218. PubMed ID: 31773399
[TBL] [Abstract][Full Text] [Related]
8. Association of ANRIL Gene Single-Nucleotide Polymorphisms With Allergic Rhinitis in Kurdish Population From Kermanshah, Iran.
Falahi S; Feizolahi P; Monshizadeh A; Mahmoudi Z; Mahdavi J; Salari F; Karaji AG; Rezaiemanesh A
Ther Adv Allergy Rhinol; 2023; 14():27534030231170874. PubMed ID: 37200985
[TBL] [Abstract][Full Text] [Related]
9. Association between long non-coding RNA polymorphisms and cancer risk: a meta-analysis.
Huang X; Zhang W; Shao Z
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802154
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males.
Zhou W; Tao Z; Wang Z; Hu W; Shen M; Zhou L; Wen Z; Yu Z; Wu X; Huang K; Hu Y; Lin X
Exp Mol Pathol; 2014 Dec; 97(3):550-3. PubMed ID: 25445501
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population.
Sattarifard H; Hashemi M; Hassanzarei S; Basiri A; Narouie B; Ghavami S
Nucleosides Nucleotides Nucleic Acids; 2019; 38(1):1-11. PubMed ID: 30587086
[TBL] [Abstract][Full Text] [Related]
13. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
[TBL] [Abstract][Full Text] [Related]
15. ANRIL polymorphisms in psoriasis vulgaris patients in northern China.
Hao S; Zhou K; Yu P; Tian J; Zhang Y; Dang L; Tong N; Li Y
Eur J Dermatol; 2022 Apr; 32(2):259-268. PubMed ID: 35866908
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in UGT2B28, UGT2B17, UGT2B15 genes and the risk of prostate cancer: A case-control study.
Habibi M; Mirfakhraie R; Khani M; Rakhshan A; Azargashb E; Pouresmaeili F
Gene; 2017 Nov; 634():47-52. PubMed ID: 28882566
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
19. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
